EyePoint Pharmaceuticals Inc

NASDAQ:EYPT

9.72

+0.06 (+0.62%)

4:38:13 PM EDT: $10.10 +0.38 (+3.91%)

Market Cap (Intraday)	673.00M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.65 Million
Adjusted EPS	-$0.82

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472

United States of America

Phone: +1.617.926.5000

Number of Employees: 165

http://www.eyepointpharma.com

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.